Breast; Cancer; Breast elastography; Elastography; Sonography Abstract Purpose: To study the diagnostic value of static elastography of the breast (score, histogram, quantitative ratio) in masses classed as BI-RADS 4 and BI-RADS 5 on sonography using the findings from pathological anatomy analyses on the masses as a reference. Materials and methods: A prospective study using a representative sample into 68 masses seen on sonography and their elastography results. For each mass, we determined the elastography colourimetry score (UENO et al. classification, scores 1-3 = benign and 4-5 = malignant). We studied quantitative elastography parameters based on the Z2/Z1 (fat/lesion) ratio and a histogram showing the pattern of mass stiffness distribution. The results were compared with histology findings (68 lesions assessed, 22 benign lesions and 46 malignant lesions). Results: Elastography was consistent with histology (sensitivity: 73.9%, specificity: 86.4%, PPV: 91.9%, NPV: 61.3%). There were twelve false negatives and three false positives. With the Z2/Z1 ratio, we set a cut-off point of 3.05 for 99.0% specificity. Conclusion: Elastography is a reliable technique that is able to assist radiologists in their diagnostic approach to breast pathology. © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
sonography is an indispensable complementary examination for the investigation of breast masses, whether they are palpable or not, with 98.4% sensitivity [1] [2] [3] . Its major strength is its ability to differentiate fluid-filled lesions from solid lesions. Its specificity is greater than that of mammography although it still remains below 50% (47.5%) [1] and the drawback is that it is dependent on the observer [4] [5] [6] [7] , their experience, and the quality of the equipment used. As with mammography and MRI, the interpretation of breast tissue nodules found on B-mode sonography relies on criteria of symptomatology and morphology. Masses are categorised using the BI-RADS tool published by the American College of Radiology (ACR), which ranks masses from 0 to 6 [8] . This classification can be refined by integrating additional criteria, such as tissue stiffness. Elastography is able to analyse differences in tissue elasticity [9] . A benign lesion is normally firmer than the surrounding breast tissue but softer than a malignant lesion [10] . This is explained by the concept of the elastic modulus or Young's modulus, a constant that links the compression strain with the deformation of an elastic material where = E ( is the strain (in units of pressure), E is the Young modulus, ε is the relative change in length). The stiffness of a malignant nodule can also be explained by the fibrous desmoplastic reaction that it provokes [11, 12] .
There are two types of elastography: static elastography, a qualitative technique that is more widely used than dynamic elastography, which is a new quantitative technique using the shear wave generated by the transducer itself. In static elastography, the imaging transducer is used to compress the tissues. A programme that calculates the strain allows the differences in elasticity from one tissue to another to be visualised in real time by displaying a colour map superimposed on the B-mode image. This technique therefore depends on the compression motion applied to the probe: it is qualitative. The information collected is represented by a colour scale that indicates minimal displacement (stiff tissue) to maximum displacement (soft tissue). Elastography is not a new technique [13] but it is not often used. Several published studies have shown it has equivalent sensitivity to B-mode sonography with greater specificity [1, [14] [15] [16] [17] . Elastography allows lesions to be classified as benign or malignant depending on the stiffness of the tissue studied using a colourimetric score and a quantitative assessment. The colourimetric score is used to categorise the lesion following UENO et al. with scores from 1 to 3 considered to be benign and scores of 4 and 5 considered to be malignant ( Fig. 1) [16] . A semi-quantitative value is obtained, which is the ratio of the stiffness of the tissue studied to the stiffness of the fatty tissue. This means that lesions can also be differentiated in terms of how aggressive they are, and this value has not been widely studied in the literature. While very high numbers of mammograms and sonograms are carried out in France, few centres are equipped with breast elastography systems.
The cost of equipment could be the factor limiting the widespread use of this technique. Moreover, carrying out elastography requires technicians to undergo a learning process that could pose constraints on the daily practice of breast radiologists. However, elastography is a simple, quick, and non-invasive technique that may be useful for assessing solid, non-palpable breast lesions, primarily those classed as BI-RADS 3 and 4 [8, 17] . The principal objective of this study is to assess the diagnostic value of static elastography of the breast (score, histogram, quantitative ratio) in masses classed as BI-RADS 4 and BI-RADS 5 on sonography, using the findings from the pathology analyses on these masses as a reference.
Materials and methods
This prospective study took place from March 2011 to June 2011. Four different operators took part in the study, and each one had been given two days of practical training in using the equipment. The engineer explained the principle of elastography to each operator before the start of their usual shift in the breast department. Then elastography as a complementary investigation was routinely carried out with the engineer's assistance on each patient who had given her prior consent (15 patients on average). A second day, one week later, was scheduled in order to check that the operator was correctly using the equipment. The operators carried out breast elastography on a daily basis, in each patient who had a mass shown on sonography during the three months before the study began.
Patients
The study included 68 patients with masses found on sonography that were classified as BI-RADS 4 and BI-RADS 5 following the ACR's sonography classification system [8] . The masses were discovered during a screening programme, routine investigations or investigations into a clinical abnormality. For each patient we listed:
• the individual variables:
• age,
• personal history of breast cancer,
• family history of breast cancer,
• the menopause and use of hormone replacement therapy (HRT);
• clinical findings:
• palpable mass, • non-palpable mass.
The inclusion and exclusion criteria in this study were: • inclusion criteria: patients with a mass found on sonography classed as BI-RADS 4 or 5 and who have had elastography and a sample taken for histological examination; • exclusion criteria: patients with masses that have not been biopsied, masses classed as BI-RADS 2 or 3 according to the ACR's sonography classification system [8] , extra-mammary masses (in the post-mastectomy chest wall or the lymph nodes), patients having neoadjuvant chemotherapy for a contralateral or adjacent lesion.
B-mode sonography
The sonography studies were carried out by four different operators on an Esaote Mylab 70 © ultrasound system commissioned in April 2006, equipped with two linear transducers from 10 to 18 MHz. Of these four operators, one was a radiologist specialised in imaging in women's health with ten years experience of sonography and a small amount of experience of elastography and three radiologists specialised in imaging in women's health whose sonography experience ranged from two to four years but who had no experience of elastography. Each mass was categorised according to the ACR's sonography classification system (BI-RADS) [8] taking into account its shape, margins, echogenicity, and posterior acoustic features. The largest measurement in millimetres (mm) was retained after the mass was measured across all three axes.
Elastography
Elastography studies were carried out during sonography of the lesions using the elastography function of the Esaote Mylab 70 © ultrasound system. Each operator had been given two days of training with patients. The ultrasound probe was placed perpendicular to the skin opposite the lesion to be investigated with the breast uniformly flattened. Then the operator carried out a repeated series of compressions and decompressions using successive uniform movements with the probe placed in the centre of the lesion. The operator was able to check that he/she was applying suitable pressure by looking at a pressure scale on the screen visible in real time. The acquisition was taken on decompression. Two screens were used with the B-mode sonography image of the lesion on the left and the corresponding elastography colour map on the right, thus assisting the operator in finding the correct position. The information collected was represented by a colour scale that encoded minimal displacement as blue (stiff tissue) ranging up to maximum displacement encoded as red (soft tissue). In this way, a colour map was created and the lesion could be categorised following the classification proposed by UENO et al. (Fig. 1 ) [16] .
In order to carry out the quantitative assessment, we marked the regions of interest (ROI) on the colour map obtained. The first ROI was marked in the lesion (zone Z1) and the second ROI in the subcutaneous fat (Z2). The ratio of Z2 to Z1 (Z2/Z1) meant that an elastography ratio could be expressed using standard deviation (Fig. 2) . From the information collected a histogram could be drawn up that showed the distribution of breast tissue stiffness within two regions of interest on a scale of 0 to 100 (Fig. 3) . For each elastography, the following were recorded:
• colourimetric score: 1, 2, 3, 4 or 5 following the classification of UENO et al. (Fig. 1) ; scores from 1 to 3 being considered to indicate a benign lesions and scores 4 and 5 malignant lesions [16] ; • quantitative result: the ROI ratio, i.e. the fat-lesion ratio (Z2/Z1); • data from the histogram of the lesion: the predominant column for lesion stiffness, whether 1, 2, 3, 4, or 5.
Histology
Lesion specimens for pathological analysis were obtained by percutaneous fine-needle biopsy alone or in combination Figure 2 . Elastography study. The colour map during an elastography study. The figure on the bottom right of the image allows the user to check they are correctly carrying out the compressiondecompression manoeuvre. The first ROI (Z1) is marked in the lesion and the second ROI (Z2) is marked in the subcutaneous fat allowing the Z2/Z1 ratio to be calculated. In this example it is calculated to be 5.35. with surgical excision when the lesion was malignant. This is considered to be the gold standard examination. These ultrasound-guided biopsies used a strict aseptic technique (the skin was disinfected with betadine or chlorhexidine) and local anaesthesia with lidocaine. We used a biopsy system with 14, 16 or 18 gauge needles (Bard system). We routinely removed three specimens per mass. The fragments obtained by percutaneous fine-needle biopsy and the specimens from the lumpectomy, tumourectomy or mastectomy obtained after surgery were examined in the pathological anatomy laboratory in order to define the histology of the lesion. Based on the pathology, results lesions were classed either as benign or malignant. Where lesions had been operated on, the diagnosis of malignancy was confirmed by analysing the excised specimen. The histologic type of each malignant lesion was defined.
Data analysis
Our study covered a representative sample. The elastography results were compared to the histology data using a non-matched Student's t test and a non-parametric Wilcoxon's test. The diagnostic performance of elastography was expressed in terms of sensitivity, specificity, positive predictive value (PPV) and negative predictive value (VPN) as compared to histology. The diagnostic values of the elastography colourimetric score and the quantitative ratio were assessed using the ROC curves method for different thresholds of colourimetric score and quantitative ratio. We carried out an analysis of covariance studying the ACR category, colourimetry, and the benign and malignant lesions. For all the tests, a P value of < 0.05 was taken as the significance threshold.
Results
Flow chart of the representative sample study that took place from March 2011 to June 2011 (Fig. 4) . Table 1 summarises the results of the study in terms of the histology of the biopsied masses.
Characteristics of the patients in the sample
The mean age of the patients was 59 years, ranging from 18 to 85 years. 30.9% of the included patients were drawn from organised screening programmes, while 69.1% of cases were found during investigation of a mass or some other clinical symptomatology. Among the patients, 79.4% had no personal history of cancer, 86.8% had no family history of breast cancer, 72.1% were postmenopausal and of these, 20.6% had been treated with HRT.
Data from B-mode sonography of 68 masses
The size of the lesions found on sonography ranged from 3 to 70 mm (mean = 13.7 mm) and 4.4% of masses were smaller than 5 mm. Twenty-five masses (36.8%) were classed as BI-RADS category 4 and 43 (63.2%) as BI-RADS 5. 
Data from elastography of 68 masses
The 68 lesions studied were categorised based on colourimetry, with a score of 2 in 14 cases (20.6%), 3 in 17 cases (25.0%), 4 in seven cases (10.3%), and 5 in 30 cases (44.1%). In total, there were 31 lesions scored as 2 and 3 and considered to be benign, making up 45.6% of the sample, and the 37 cases scored as 4 and 5 and considered to be malignant made up 54.4% of the sample. The Z2/Z1 ROI ratio ranged from 0.3 to 7.4 with a mean of 3.4. Column 1 of the histogram was the largest in 44 cases or 64.7%, column 2 in 14 cases (20.6%), column 3 in seven cases (10.3%), column 4 in one case (1.5%), column 5 in two cases (2.9%).
Pathology diagnosis of 68 lesions
Forty-six lesions were malignant (67.6%) and 22 lesions were benign (32.4%) ( Table 2) .
Diagnostic performance of elastography
Elastography colourimetry scores of the sample (n = 68) compared to histology: of the 46 malignant lesions, 34 lesions (73.9%) had a colourimetry score of 4 or 5 and 12 (26.1%) had a colourimetry score of 1, 2 or 3. Of the 22 benign lesions, 19 lesions (86.4%) had a score of 1, 2 or 3 and three (13.6%) scored 4 or 5. (Table 3 ). The histology results of the 12 false negatives found on elastography showed six invasive ductal carcinomas (grade I = 2, grade II = 3, grade III = 1), two invasive lobular carcinomas (grade II = 2), one mucinous-type cancer, one ductal carcinoma in situ, one lymph node tumour proliferation and 1 B-cell lymphoma localised to the breast. Five of these false negatives were classed as BI-RADS 4 (Fig. 5) . The histology results of the three false positives found on elastography (three scores of 5) showed one sclerosing adenosis, one radial scar and one breast that was the site of inflammatory changes. These lesions were classed as BI-RADS 5 on B-mode sonography (Fig. 6) .
The results of our study show that elastography colourimetry score has an increased sensitivity (73.9%) and specificity (86.4%) as well as a higher PPV of 91.9% (Table 3) with an ROC curve showing a wide area under the curve of 0.813 (confidence interval of 95%) (Fig. 7) . Of 68 lesions, 43 nodules (63.2%) were classed as BI-RADS 5, and 25 as BI-RADS 4 (36.8%).
Comparing the elastography colourimetry score of the BI-RADS 5 masses to the histology results, we found the following: of the 43 lesions classed as BI-RADS 5, histology showed 37 malignant lesions and six benign lesions (Table 4) . Histology results of the six false positives found on sonography (classed as BI-RADS 5 but histology was benign) found one benign lesion, one sclerosing adenosis, one radial scar, one granular cell tumour, one case of adipose tissue fibrosis and one breast that was the site of inflammatory changes. Of these six false positives, the elastography colourimetry score was concordant: one lesion scored as 2 (the benign lesion) meaning it was a soft lesion, two lesions scored as 3, having soft consistencies (the granular cell tumour and the case of adipose tissue fibrosis), and three lesions were scored as 5 (the sclerosing adenosis, the radial scar and the inflammatory changes) of which two had a stiffer consistency (the sclerosing adenosis and the radial scar). (Table 5) . Of the nine malignant lesions, four were invasive ductal carcinomas, two were ductal carcinomas in situ, one was an invasive lobular carcinoma, one was a large B-cell lymphoma localised to the breast and one was a lymph node tumour proliferation. The corresponding elastography score fell under benign with a score of 2 for the two lymphomas and 3 for the invasive lobular carcinoma, which had a slightly less stiff consistency.
Analysis of the Z2/Z1 ratios of the sample based on elastography data (n = 68)
The ROI ratios ranged from 0.3 to 7.4 with a mean value of 3.4. The higher the Z2/Z1 ratio, the more likely the histology results would show a malignant lesion, with a mean ratio of 4.2 for malignant lesions, and the lower the Z2/Z1 ratio, the more likely it was that the histology results would show a benign lesion, with a mean ratio of 1.7 for benign lesions. Twenty-four malignant lesions of the 46 (52.2%) found in the study had a Z2/Z1 ratio higher than or equal to 4.3. The corresponding ROC curve (Fig. 8) showed a larger area under the curve of 0.860 (95% CI).
Analysis of the histogram encoding the distribution of tissue stiffness of the sample (n = 68)
The malignant lesions had a mean value of 1.20 in their largest column. The benign lesions had a mean value of 2.4 in their largest column. Of the 44 cases in which column 1 of the histogram was the largest, 39 (84.7%) were malignant lesions. The five false positives corresponded to a radial scar, one fibroadenoma, one lesion that was the Table 5 Performance of elastography colourimetry score in masses classed as ACR 4 compared to histology findings (n = 25). site of granulomatous inflammatory changes, one breast with no suspicious findings and one breast with dystrophic parenchyma and no atypical findings.
Discussion
Based on the results of this study, we can estimate the diagnostic value of elastography because a good correlation was found between the elastography scores and the histology results. In our study, the PPV of elastography was 91.9%, higher than results from the literature with the Tardivon et al. study finding a PPV of 85.7% [1] . The NPV of elastography was 61.3%, lower than the results found in the Tardivon et al. study in which the NPV was 80.3% [1] . The sensitivity of elastography was 73.9%, slightly lower than results from the literature in which it ranges from 77.6% to 86.5% [1, 18, 19] . The specificity of elastography was 86.4%, which was a similar result to those in the literature (from 84.7% to 89.8%) [1, 18, 19] . The results from our study show higher sensitivity and specificity for the elastography colourimetry score with an ROC curve showing a wide area under the curve of 0.813. Leong et al. had similar results, with an area under the curve of 0.869 [1] . In our study, of the 12 false negatives, six were invasive ductal cancers, two were invasive lobular cancers, one was a mucinous-type and one was a ductal carcinoma in situ. These results are consistent with those in the literature. In the Tardivon et al. series (61 malignant lesions and 61 benign lesions) the histology of the 13 false negatives (scores 1, 2 and 3) revealed invasive ductal cancers (n = 8), invasive lobular cancers (n = 3), one mucinous-type cancer and one papillary carcinoma [1] . In the Giuseppetti et al. series (91 nodules), the histology of 13 false negatives (elastography scores of 2 and 3) showed mixed-type invasive carcinomas (n = 6), invasive lobular type (n = 3) and ductal cancers (n = 4) [18] . Our study showed a good correlation between the elastography scores and the firmness of the tissue studied, which is the very principle of this technique. Indeed the elastography false positives were found among the lesions that had structures with a firm or fibrous consistency meaning that they were assigned an inappropriately high score (sclerosing adenosis, fibrous mastopathy, radial scar) and could be connected to lesions being partly calcified.
Of the 12 false negatives found on elastography, two lesions were lymph node tumour proliferation and one was a lymphoma localised to the breast, which had quite soft consistencies. This could be because they contained fluid, which would explain their relative softness on elastography. There was one mucinous cancer with a gelatinous consistency due to abundant mucous secretion. There were also two lobular cancers and one cancer in situ. For these latter three lesions, their benign colourimetry score is explained by the fact that there was no desmoplastic fibrous reaction.
Of the six false negatives corresponding to invasive ductal carcinomas, four of these were found early on in the study when the operators were still perfecting their technique. These six lesions had quite disparate sizes (ranging from 5 to 22 mm with one lesion of 20 mm and one of 22 mm), so we are unable to state that size has an influence based on such a limited number of lesions, although in the literature elastography is reported to perform better for lesions smaller than 20 mm [18] .
Our study also showed the Z2/Z1 ratio to have increased sensitivity and specificity with an analysis of the ROC curve showing a wide area under the curve of 0.860 (Fig. 7) . The higher the Z ratio, the more likely the histology results would point to a malignant lesion, and the lower the Z2/Z1 ratio, the more likely it was that the histology results would point to a benign lesion. Since the aim of using elastography is to return fewer false positives and more true negatives, it is essential that this examination has higher specificity and so the cut-off point of the Z2/Z1 ratio was set at 3.05 to correspond to a sensitivity of 69.6% and a specificity of 99.0%. In the literature the cut-off point is slightly higher, at 4.3, with a specificity of 88.8% and a sensitivity of 89.4% [20] . The histogram is an interesting complementary resource for assessing the stiffness of the nodule studied according to the distribution pattern of its firmness. This is not studied in the literature. Our study did find a good correlation between stiffness being concentrated in the first column of the histogram and malignant lesions. A concentration of lesion stiffness located in column 1 of the histogram pointed to a malignant lesion (84.8% of malignant lesions) while a more evenly spread distribution and/or being located in column 2, 3, 4 or 5 pointed to a benign lesion. The whole value of this technique rests in the analysis of masses classed as BI-RADS 4, a heterogeneous group within which the cancer rate varies from 30.0% to 70.0%. In our study, of the 25 lesions classed as BI-RADS 4, nine turned out to be malignant lesions. A malignant elastography score was found in four cases out of nine. In two of these nine cases, the elastography score was low but the lesions were a lymph node tumour proliferation and a lymphoma localised to the breast, so they involved breast tissue of a less stiff consistency.
The study had some limitations: the sample was small, consisting of only 69 patients, of which 68 cases were analysed. In the literature, the Tardivon et al. study covered 122 lesions, Leong et al. reviewed 99 lesions and Itoh et al., 135 lesions. The study was conducted in the Breast Disease department at the Tours CHRU (regional university hospital) on a population that differed from the general population, which explains the variation found in histological types (lymphoma, papillary, mucinous and apocrine carcinomas). Four operators took part in the study but we do not have sufficient data to study conclusively the reproducibility of the elastography assessments. Use of this technique has a steep learning curve. In this context, it is important to note that nine of the 12 false negatives found on elastography arose in the first 30 days of the study, and this was because the operators were still perfecting use of the equipment. This phenomenon is also found in the literature [1, 16] . It is therefore essential that operators have time to learn how to use the equipment because a rigorous technique requires a good understanding of the assessment tools (setting the ROI in the structures studied) as well as learning the decompression technique. The technique is operator-dependent because the mechanical manoeuvres that need to be carried out influence the image and, in turn, the elastography score, which could be a source of interpretation errors and the reproducibility of the results is difficult to evaluate. This brings us to another limitation, which is that the dynamic investigation cannot be recorded so it is impossible to look at the examinations again. This means that any quality assessment of the imaging carried out is compromised, as is the validity of the results. Similarly, assessing the progress of the operators as they learn to perform the examination is even more difficult. Elastography produces qualitative results, dependent on the compression motion applied to the transducer, which may vary from one user to another. A new technique using ShearWave TM elastography involves the transducer itself producing an ultrasonic shear wave and measuring how quickly it propagates to the tissues. This technique requires a new elastography system that acquires 20,000 images a second. This new imaging technique enables tissue elasticity to be measured in real time, in a reproducible way that is not userdependent and produces quantitative results (in kilopascals) [21, 22] .
We could extend this study to cover masses of indeterminate nature classed as BI-RADS category 3 in order to investigate whether elastography could lead to patients not having to undergo repeated monitoring if it has good NPV, or perhaps whether it could guide biopsies and give weight to a recommendation for repeated monitoring in cases of solid lesions with no morphological findings suspicious for malignancy.
Conclusion
Our study proved that there is a good correlation between the diagnostic findings of static elastography of the breast in masses classed as BI-RADS 4 and BI-RADS 5 and sonography, using the results of pathology analyses on the masses as a reference, with a PPV of 91.9%. Static elastography of the breast is a reliable technique that can assist radiologists in their approach to diagnosing breast pathologies. It is simple to put into practice on a daily basis because it retains all the functionality of traditional sonography, in that it is quick to carry out and it is safe. However, this technique remains qualitative and operator-dependent.
